Head-to-head · Value Score
Trimi Health vs Invyncible
Two GLP-1 deals, scored on the same six factors. Trimi Health lands a Value Score of 89, Invyncible a 68. Here's who gives you the honest lower price — and where each one bites back.
Trimi Health
#3 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameInvyncible
#279 · Grade C · Watch List
Est. first month
From $192/mo (starting dose, compounded)
Save ~86% vs brand-nameThe verdict
Trimi Health takes it on Value Score, 89 to 68 — an est. $99/mo first month, with no teaser step-up baked in. Invyncible isn't out of it: Shoppers who want corporate-parent-disclosed Florida GLP-1 platform with LegitScript seal.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Trimi Health | Invyncible |
|---|---|---|
| Value Score | 89 (A) | 68 (C) |
| Est. first month | $99/mo | From $192/mo (starting dose, compounded) |
| Save vs brand-name | ~93% | ~86% |
| Semaglutide | $99/mo | From $192/mo (starting dose, compounded) |
| Tirzepatide | $125/mo | From $210/mo (compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | 40 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Trimi Health
The ultra-budget pick: two-digit semaglutide and a $125 tirzepatide — one of the lowest flat tirz stickers on the whole board — shipped to all 50 states.
Why it's a deal
- Ultra-budget on both molecules — $99 semaglutide and a class-low $125 tirzepatide, flat with no teaser step-up
- Tirzepatide at $125/mo undercuts most of the flat-fee field on the priciest molecule
- Nationwide 50-state reach, so the low price isn't gated to a handful of states
The fine print
- Not LegitScript-certified — do your own pharmacy diligence before you buy on price alone
- Compounded injectable only — no FDA-approved brand-name or oral/sublingual route
- Newer brand with a thin public track record
Invyncible
Invyncible is a Florida-based telehealth platform offering semaglutide and tirzepatide programs for weight management.
Why it's a deal
- Corporate parent disclosed (Nationwide Telemedicine, LLC) — better than most competitors hiding behind trade names
- Physical corporate address published (St. Petersburg, FL)
- LegitScript verification seal displayed
- No long-term commitment required
- Offers both semaglutide and tirzepatide programs
The fine print
- Pricing not disclosed on the public site — fully gated behind signup
- Drug forms (compounded vs brand, injection vs oral) not disclosed
- 503A vs 503B designation not specified
- Pharmacy partner not named
- States served not listed publicly
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Trimi Health is ranked on the Trimi Health alternatives board, and the same list for the other side is on alternatives to Invyncible.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.